J&J loses challenge to $302M judgment over pelvic mesh marketingBusiness, FDA/Regulatory, TherapeuticsThe U.S. Supreme Court on Tuesday let stand a $302 million judgment against Johnson & Johnson in a lawsuit brought by the state of California accusing the company of concealing the risks of its pelvic mesh products. Read more February 21, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2023/02/ReutersJNJ2-21-2023.jpg 800 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-02-21 11:44:392023-02-21 12:41:22J&J loses challenge to $302M judgment over pelvic mesh marketing
